Closed · 7200AA23RFA00002 · CFDA 98.001 · Other

HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA)

Federal grant opportunity posted by Agency for International Development, cataloged on Grants.gov.

$46M-$46M
Award range
Closed
Status
May 31, 2023
Close date
2
Expected awards

The verdict

HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA) is a closed other listing from Agency for International Development that offered $46,000,000 -- $46,000,000 across 2 expected awards. Future funding cycles may be published under the same CFDA number.

$46M-$46M
award range
Closed
application status
2
expected awards
98.001
CFDA program

Opportunity snapshot. This Grants.gov announcement - HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA) - is cataloged under number 7200AA23RFA00002 and tied to CFDA assistance listing 98.001, posted by Agency for International Development. Grants.gov currently shows the opportunity as closed, first posted on November 17, 2022 and last updated on April 10, 2023. The funding category is Other, delivered as a cooperative agreement.

Award economics. The award range on file is $46,000,000 -- $46,000,000. It expects to issue 2 awards. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.

Deadline and action path. This opportunity closed on May 31, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.

Award Range

$46,000,000 -- $46,000,000

Close Date

May 31, 2023

Posted

November 17, 2022

Expected Awards

2

Instrument

Cooperative Agreement

Description

The objective of the HIV-VISTA Project is to support sub-Saharan African scientists, institutions, and innovative systems of collaboration in designing and testing improved HIV vaccine candidates that will advance the field toward the long-term goal of a safe and globally-effective HIV vaccine. Activities should be implemented in at least three different countries in sub-Saharan African Closing Date and Time for CONCEPT NOTE: Friday January 20, 2023; 4:00 PM, Washington DC local time Closing Date and Time for FULL APPLICATION (INVITATION ONLY): Wednesday May 31, 2023; at 4:00 PM, Washington DC local time Note: All Applicants that fit the Eligibility criteria are welcome to submit concept notes. At the concept stage, please submit proof documentation the eligibility. However, request for Full Application will be based on invitation. Therefore in order to be considered, all eligible Applicants interested must submit concept note by deadline to be considered for co-creation and Full Application. Please download and read all the relevant documents especially the NOFO Amendment 2 to understand the process. (UPDDATE APRIL 10, 2023: The process for concept notes has been closed.)

Eligibility

Grants.gov lists this opportunity under eligibility category codes 06, 12, 13, 20, 22, 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Simone Cho A&A Specialist

Key Dates

Posted November 17, 2022
Close Date May 31, 2023
Archive Date June 2, 2023
Last Updated April 10, 2023

Frequently Asked Questions

What is this grant opportunity?
This is a federal funding opportunity titled "HIV Vaccine Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA)", offered by Agency for International Development. It is associated with CFDA program 98.001. The objective of the HIV-VISTA Project is to support sub-Saharan African scientists, institutions, and innovative systems of collaboration in designing and testing improved HIV vaccine candidates that...
Is this opportunity still open?
No, this opportunity is closed. It closed on May 31, 2023. Check the parent program page for future funding cycles.
How much funding is available?
The award range for this opportunity is $46,000,000 -- $46,000,000. Expected number of awards: 2.
How do I apply?
Applications for federal grant opportunities are typically submitted through Grants.gov. Visit the official listing at grants.gov for application instructions, required documents, and submission deadlines.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants